White Paper

Agile Process Development In Biopharmaceuticals

Agile Process Development In Biopharmaceuticals

The development of novel therapeutic products involves a complex network of internal departments and external partners. Different groups across Process Development organizations typically use a variety of approaches to capture, manage, analyze and report data.

These can range from paper and Excel, to in-house developed electronic systems or commercial solutions. Regardless of their IT maturity, the lack of a consistent approach has a negative impact on the agility of the business including:

  • Process scientists are unable to identify issues in a timely manner, resulting in a reactive approach to problems
  • Reports take time to compile and are out of date as soon as they are created
  • Critical decisions are made based on incomplete information

This whitepaper describes the business benefits Process Development teams can expect to achieve and by taking a platform approach.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of ECM Connection? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: